Literature DB >> 15164157

Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.

Andrew C Harris1, Stephanie L Hanes, Jonathan C Gewirtz.   

Abstract

RATIONALE: Administration of an opiate antagonist following acute morphine exposure elevates the startle response in rodents, a phenomenon that may reflect the anxiogenic effects of withdrawal. Previous acute dependence studies have demonstrated escalated withdrawal severity following multiple withdrawal episodes.
OBJECTIVES: To examine the effects of prior opiate exposure on the magnitude of withdrawal-potentiated startle and an additional measure of acute dependence, withdrawal-induced hyperalgesia.
METHODS: The effects of repeated naloxone-precipitated morphine withdrawals on acoustic startle responding were evaluated in experiments that varied either the dose of the opiate antagonist (8-day, repeated measures procedure) or agonist (3-day procedure). Additional experiments examined withdrawal-induced hyperalgesia utilizing either a single-day dependence paradigm or the same 3-day procedure as in the startle experiment.
RESULTS: Repeated naloxone-precipitated withdrawals from acute morphine exacerbated withdrawal severity in both startle procedures, although this effect varied biphasically (inverted-U function) with morphine dose in the 3-day dependence paradigm. Withdrawal from a single morphine exposure also induced hyperalgesia, and this effect was intensified by prior withdrawal episodes.
CONCLUSIONS: These data demonstrate that repeated withdrawals from acute morphine exacerbate the severity of potentiated startle and hyperalgesia. These paradigms may be useful in examining the neural plasticity underlying the development of opiate dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164157     DOI: 10.1007/s00213-004-1889-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

Review 2.  Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle.

Authors:  D L Walker; J V Cassella; Y Lee; T C De Lima; M Davis
Journal:  Neurosci Biobehav Rev       Date:  1997-11       Impact factor: 8.989

3.  Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.

Authors:  J U Adams; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

Review 4.  The neuroanatomical and neurochemical basis of conditioned fear.

Authors:  M Fendt; M S Fanselow
Journal:  Neurosci Biobehav Rev       Date:  1999-05       Impact factor: 8.989

5.  Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine.

Authors:  D R Meyer; S B Sparber
Journal:  Life Sci       Date:  1977-10-15       Impact factor: 5.037

6.  Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training.

Authors:  M Davis; D I Astrachan
Journal:  J Exp Psychol Anim Behav Process       Date:  1978-04

7.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat.

Authors:  B C Yoburn; J Chen; T Huang; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

8.  Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.

Authors:  Victoria B Risbrough; Richard L Hauger; Mary Ann Pelleymounter; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

9.  Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.

Authors:  L P Dwoskin; B S Neal; S B Sparber
Journal:  Eur J Pharmacol       Date:  1983-06-03       Impact factor: 4.432

10.  The acoustic startle response as a measure of behavioral dependence in rats.

Authors:  R S Mansbach; L H Gold; L S Harris
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  17 in total

1.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 2.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

Review 3.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

4.  Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats.

Authors:  Yayi Swain; Peter Muelken; Annika Skansberg; Danielle Lanzdorf; Zachary Haave; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

5.  Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats.

Authors:  Jeffrey M Engelmann; Anna K Radke; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2009-08-11       Impact factor: 4.530

6.  Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.

Authors:  Kathryn L Hamilton; Andrew C Harris; Jonathan C Gewirtz
Journal:  Brain Res       Date:  2013-09-26       Impact factor: 3.252

7.  Effects of acute morphine withdrawal on ultrasonic vocalizations in adult rats: unchanged 50-kHz call rate and altered subtype profile.

Authors:  YiQi C Lin; Leah L Zhao; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2018-04-16       Impact factor: 4.530

8.  Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.

Authors:  Andrew C Harris; Patrick E Rothwell; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2007-11-16       Impact factor: 4.530

9.  Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat.

Authors:  Ziva D Cooper; Yen Nhu-Thi Truong; Yong-Gong Shi; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2008-05-30       Impact factor: 4.030

10.  Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.

Authors:  Andrew C Harris; Katherine E Manbeck; Clare E Schmidt; David Shelley
Journal:  Psychopharmacology (Berl)       Date:  2012-08-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.